# Smoking Relapse Prevention Among COPD Ex-smokers

> **NCT02888444** · PHASE3 · TERMINATED · sponsor: **University of Auckland, New Zealand** · enrollment: 8 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Smoking Cessation

## Interventions

- **DRUG:** Varenicline
- **BEHAVIORAL:** Behavioural support
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02888444
- **Lead sponsor:** University of Auckland, New Zealand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-31
- **Primary completion:** 2018-04-13
- **Final completion:** 2018-04-13
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888444, "Smoking Relapse Prevention Among COPD Ex-smokers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02888444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*